Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -97,908 | -61,120 | -36,941 | -17,266 | -52,451 |
| Depreciation Amortization | 526 | 395 | 263 | 135 | 532 |
| Accounts payable and accrued liabilities | 5,585 | 1,769 | -30 | -1,096 | -4,696 |
| Other Working Capital | 7,863 | 2,625 | 464 | -479 | -2,577 |
| Other Operating Activity | -955 | 1,460 | 1,874 | 1,929 | 16,987 |
| Operating Cash Flow | $-84,889 | $-54,871 | $-34,370 | $-16,777 | $-42,205 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,000 | 12,000 | 12,000 | 8,000 | -9,600 |
| PPE Investments | N/A | N/A | N/A | N/A | -17 |
| Investing Cash Flow | $12,000 | $12,000 | $12,000 | $8,000 | $-9,617 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6,329 | -6,329 | -2,667 | -1,333 | -5,333 |
| Common Stock Issued | 408 | 56,203 | 59,267 | 3,081 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | 140 |
| Other Financing Activity | 103,862 | 47,879 | -2,743 | -260 | 66,265 |
| Financing Cash Flow | $97,941 | $97,753 | $53,857 | $1,488 | $61,072 |
| Beginning Cash Position | 40,394 | 40,394 | 40,394 | 40,394 | 31,144 |
| End Cash Position | 65,446 | 95,276 | 71,881 | 33,105 | 40,394 |
| Net Cash Flow | $25,052 | $54,882 | $31,487 | $-7,289 | $9,250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,889 | -54,871 | -34,370 | -16,777 | -42,205 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -17 |
| Free Cash Flow | -84,889 | -54,871 | -34,370 | -16,777 | -42,222 |